Octavio Espinoza, Chief Financial Officer at LIGAND PHARMACEUTICALS INC (LGND), sold 31,641 shares at $292.06 ($9.2M) on 2026-08-12, disclosed to the SEC on 2026-08-14.
Scheduled sale ($9.2M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| LGND | SELL | 2025-12-16 | $679K | — | Filing → |
| LGND | BUY | 2025-05-13 | $156K | — | Filing → |
| LGND | SELL | 2025-03-06 | $575K | — | Filing → |